Project Number 5U01AG031115-05 Agency/Funding Organization NIA Funding Year 2012 View Full Project Details for DEVELOPMENT OF ALLOPREGNANOLONE AS A NEUROGENIC REGENERATIVE THERAPEUTIC Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 4. Non-clinical Drug Development (small molecules and biologics) r. Multi-target Researcher and Organization Principal Investigator BRINTON, ROBERTA EILEEN Principal Investigator First Name ROBERTA Principal Investigator Last Name BRINTON Awardee Organization UNIVERSITY OF SOUTHERN CALIFORNIA Awardee State California Contact PI Country United States Project Detail Funding Opportunity Announcement PAR-05-158: NINDS COOPERATIVE PROGRAM IN TRANSLATIONAL RESEARCH FY Overall Cost $173,913 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official PETANCESKA, SUZANA Related Resources Repository [AlzPED] Allopregnanolone reverses neurogenic and cognitive deficits in mouse model of Alzheimer's disease
